AFP and hepatocellular carcinoma: Currently, alpha-fetoprotein (AFP) is a generally used diagnostic and prognostic aid for HCC, but its lack of sufficient specificity and sensitivity limits its clinical application (Wang & Zhang, 2020; Zhang et al., 2020b).